Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Consider endogenous TCR KO #10

Open
hammer opened this issue Nov 5, 2019 · 1 comment
Open

Consider endogenous TCR KO #10

hammer opened this issue Nov 5, 2019 · 1 comment
Assignees

Comments

@hammer
Copy link
Member

hammer commented Nov 5, 2019

When I discussed this work at a high level with Alex Marson he was quite skeptical that we should see T cell killing for 4 different TCRs without having to KO the endogenous TCR for any of them. He claims that his lab has found the requirement for endogenous TCR KO to be TCR-dependent but quite common. If we are going to expend the energy to KO HLA from the cancer cell line, we may as well try to KO the endogenous TCR from the T cells.

@pinarden
Copy link

pinarden commented Nov 6, 2019

It's interesting to hear that the KO requirement is TCR-dependent. In any case, we have good preliminary data with the OT-I TCR both for mouse T cells and human T cells. Because we are not interested in achieving the highest cytotoxicity but we're interested in showing that these TCRs are reactive to those peptides, we can bypass endogenous TCR KO. If our first trial fails, then we should consider this. Thank you!

Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Labels
None yet
Projects
None yet
Development

No branches or pull requests

3 participants